U.S. Pledges $708 Million to Manufacture COVID-19 Vaccines in South Africa
ADF STAFF
The U.S. has announced a $708 million investment plan to help South African pharmaceutical company Aspen Pharmacare produce more than 500 million COVID-19 vaccine doses for African nations by the end of 2022.
The financing…